1. Wang XY, et al. An Integrated System for Screening Tumor-Specific TCRs, Epitopes, and HLA Subtypes Using Single-Cell Sequencing Data. J Immunother Cancer 2025; 13(7): e012029. (影响因子10.6,中科院一区Top期刊) 2. Jin SK, Zhang Y, et al, Wang XY*. Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer. MedComm 2026; Accepted. (影响因子10.7,中科院一区Top期刊) 3. Wang XY, et al. Mesenchymal stem cells carriers enhance antitumor immunity induced by oncolytic reovirus in acute myeloid leukemia. Int Immunopharmacol 2021; 94: 107437. (影响因子5.7) 4. Wu LW, Zhang LZ, et al, Wang XY*. Mesenchymal Stem Cell-derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis. Biomolecules 2024; 14(11): 1353. (影响因子4.8) 5. An YY#, Wang XY#, et al. Oncolytic reovirus induces ovarian cancer cells apoptosis in a TLR3 dependent manner. Virus Res 2021; 301: 198440. (影响因子6.286) 6. Huang ML, et al, Wang XY*. Advancements in research on mesenchymal stem cell-derived exosomal miRNAs: A pivotal insight into aging and age-related diseases. Biomolecules 2024; 14(11): 1354. (影响因子4.8) |